As we head toward U.S. elections we’re dedicating a portion of our coverage to related issues. Last week, for example, we published The Psychedelics Lobby, which tracks federal lobbying efforts among psychedelic drug developers and nonprofit advocacy groups. Having looked at how the psychedelics field is exerting its influence at the federal level, in this Interview we look at how incumbent…
